Skip to content
healthcare.dev
Get a free key

NUVAXOVID 2026-27

NDC 49281-026, NVX-COV2928, injection, suspension, from Sanofi Vaccines US Inc..

Product NDC
49281-026
Status
Listed
Labeler
Sanofi Vaccines US Inc.
Dosage form
INJECTION, SUSPENSION
Route
INTRAMUSCULAR
Product type
VACCINE
Marketing category
BLA
Application
BLA125817
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/49281-026 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NVX-COV29285 ug/.5mL
Package NDCNDC-11Package
49281-026-504928100265010 SYRINGE in 1 CARTON (49281-026-50) / .5 mL in 1 SYRINGE (49281-026-88)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 49281-026 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/49281-026 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 49281-026. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.